ADRIANA DE SOUZA Azevedo

Dr. ADRIANA DE SOUZA Azevedo

Institute of Technology in Immunobiologicals (Bio-Manguinhos), Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Virology
Verified
Journal Article
Closed access
SCS.M. Costa
S.M. Costa
AAADRIANA DE SOUZA Azevedo
ADRIANA DE SOUZA Azevedo
MPMarciano Paes
Marciano Paes
FSF.S. Sarges
F.S. Sarges
MFM.S. Freire
M.S. Freire
AAA.M.B. Alves
A.M.B. Alves

9 December 2015 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
AGAntônio J. S. Gonçalves
Antônio J. S. Gonçalves
Edson OliveiraEdson Oliveira
Edson Oliveira
SCSimone M. Costa
Simone M. Costa
MPMarciano Paes
Marciano Paes
JSJuliana F. A. Silva
Juliana F. A. Silva
AAAda Maria de Barcelos Alves
Ada Maria de Barcelos Alves
Dengue virus (DENV) is spread through most tropical and subtropical areas of the world and represents a serious public health problem. At present, the control of dengue disease is mainly hampered by the absence of antivirals or a vaccine, which results in an estimated half worldwide population at risk of infection. The immune response against DENV is not yet fully understood and a better knowledge of it is now recognized as one of the main challenge for vaccine development. In previous studies, we reported that a DNA vaccine containing the signal peptide sequence from the human tissue plasminogen activator (t-PA) fused to the DENV2 NS1 gene (pcTPANS1) induced protection against dengue in mice. In the present work, we aimed to elucidate the contribution of cellular and humoral responses elicited by this vaccine candidate for protective immunity. We observed that pcTPANS1 exerts a robust protection against dengue, inducing considerable levels of anti-NS1 antibodies and T cell responses. Passive immunization with anti-NS1 antibodies conferred partial protection in mice infected with low virus load (4 LD50), which was abrogated with the increase of viral dose (40 LD50). The pcTPANS1 also induced activation of CD4+ and CD8+ T cells. We detected production of IFN-γ and a cytotoxic activity by CD8+ T lymphocytes induced by this vaccine, although its contribution in the protection was not so evident when compared to CD4+ cells. Depletion of CD4+ cells in immunized mice completely abolished protection. Furthermore, transfer experiments revealed that animals receiving CD4+ T cells combined with anti-NS1 antiserum, both obtained from vaccinated mice, survived virus infection with survival rates not significantly different from pcTPANS1-immunized animals. Taken together, results showed that the protective immune response induced by the expression of NS1 antigen mediated by the pcTPANS1 requires a cooperation between CD4+ T cells and the humoral immunity. Dengue is an emerging mosquito-borne disease present in an extensive area of the globe with an estimated risk exposure of half of the world’s population. Unfortunately, no specific treatment or vaccine is available to control this disease, which leads to approximately 20,000 casualties annually. The protective immune response against this pathogen consists of an important goal for the development of anti-dengue strategies. For years, the presence of neutralizing antibodies was believed to represent the major response for protection against dengue. However, a recent clinical trial showed that despite the induction of a balanced antibody response against all serotypes, vaccination had only a partial efficacy. In the present work, we aimed to elucidate the contribution of the cellular and humoral responses elicited by a DNA vaccine candidate encoding the non-structural 1 protein (NS1) from dengue virus. We observed that antibody as well as T cell responses are important for protection against dengue in a cooperative way. Our results demonstrated that an effective defense against virus was not achieved with antibodies or T cells alone, but rather with the combination of both responses. Therefore, we suggest that an ideal vaccine against dengue should induce both arms of the immune system.

1 February 2016 in Virology
Verified
Journal Article
Closed access
Edson OliveiraEdson Oliveira
Edson Oliveira
JAJ.F.S. Amorim
J.F.S. Amorim
MPMarciano Paes
Marciano Paes
AAADRIANA DE SOUZA Azevedo
ADRIANA DE SOUZA Azevedo
AGA.J.S. Gonçalves
A.J.S. Gonçalves
AAAda Maria de Barcelos Alves
Ada Maria de Barcelos Alves

11 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAADRIANA DE SOUZA Azevedo
ADRIANA DE SOUZA Azevedo
AYAnna M Y Yamamura
Anna M Y Yamamura
MFMarcos S Freire
Marcos S Freire
GTGisela Freitas Trindade
Gisela Freitas Trindade
MBMyrna Bonaldo
Myrna Bonaldo
AAAda Maria de Barcelos Alves
Ada Maria de Barcelos Alves
Two DNA vaccines were constructed encoding the ectodomain (domains I, II and III) of the DENV2 envelope protein (pE1D2) or only its domain III (pE2D2), fused to the human tissue plasminogen activator signal peptide (t-PA). The expression and secretion of recombinant proteins was confirmed in vitro in BHK cells transfected with the two plasmids, detected by immunofluorescence or immunoprecipitation of metabolically labeled gene products, using polyclonal and monoclonal antibodies against DENV2. Besides, results reveal that the ectodomain of the E protein can be efficiently expressed in vivo, in a mammalian system, without the prM protein that is hypothesized to act as a chaperonin during dengue infection. Balb/c mice were immunized with the DNA vaccines and challenged with a lethal dose of DENV2. All pE1D2-vaccinated mice survived challenge, while 45% of animals immunized with the pE2D2 died after infection. Furthermore, only 10% of pE1D2-immunized mice presented some clinical signs of infection after challenge, whereas most of animals inoculated with the pE2D2 showed effects of the disease with high morbidity degrees. Levels of neutralizing antibodies were significantly higher in pE1D2-vaccinated mice than in pE2D2-immunized animals, also suggesting that the pE1D2 vaccine was more protective than the pE2D2.

26 March 2020 in Viruses
Verified
Journal Article
Open access
PDF file
FAFilipe Abreu
Filipe Abreu
AFAnielly Ferreira-De-Brito
Anielly Ferreira-De-Brito
AAADRIANA DE SOUZA Azevedo
ADRIANA DE SOUZA Azevedo
JLJosé Henrique Linhares
José Henrique Linhares
VSVanessa de Oliveira Santos
Vanessa de Oliveira Santos
RLRicardo Lourenço-de-Olveira
Ricardo Lourenço-de-Olveira
In the last decade, Flaviviruses such as yellow fever (YFV) and Zika (ZIKV) have expanded their transmission areas. These viruses originated in Africa, where they exhibit both sylvatic and interhuman transmission cycles. In Brazil, the risk of YFV urbanization has grown, with the sylvatic transmission approaching the most densely populated metropolis, while concern about ZIKV spillback to a sylvatic cycle has risen. To investigate these health threats, we carried out extensive collections and arbovirus screening of 144 free-living, non-human primates (NHPs) and 5219 mosquitoes before, during, and after ZIKV and YFV outbreaks (2015–2018) in southeast Brazil. ZIKV infection was not detected in any NHP collected at any time. In contrast, current and previous YFV infections were detected in NHPs sampled between 2017 and 2018, but not before the onset of the YFV outbreak. Mosquito pools screened by high-throughput PCR were positive for YFV when captured in the wild and during the YFV outbreak, but were negative for 94 other arboviruses, including ZIKV, regardless of the time of collection. In conclusion, there was no evidence of YFV transmission in coastal southeast Brazil before the current outbreak, nor the spread or establishment of an independent sylvatic cycle of ZIKV or urban Aedes aegypti transmission of YFV in the region. In view of the region’s receptivity and vulnerability to arbovirus transmission, surveillance of NHPs and mosquitoes should be strengthened and continuous.

1 January 2022 in Vaccine
Verified
Journal Article
Closed access
LRLaise Rodrigues Reis
Laise Rodrigues Reis
ICIsmael Artur Costa-Rocha
Ismael Artur Costa-Rocha
ACAna Carolina Campi-Azevedo
Ana Carolina Campi-Azevedo
VPVanessa Peruhype-Magalhães
Vanessa Peruhype-Magalhães
JCJordana Grazziela Coelho-Dos-Reis
Jordana Grazziela Coelho-Dos-Reis
OMOlindo Martins-filho
Olindo Martins-filho